Vinay Prasad, CoronavirusModerna Agrees to Placebo-Controlled Trial for New mRNA COVID Vaccine50% right coverage4 sources
Vinay Prasad, CoronavirusModerna Agrees to Placebo-Controlled Trial for New mRNA COVID Vaccine50% right coverage4 sources
Vinay Prasad, FDACDC Updates COVID-19 Vaccine Guidance for Children, Pregnant Women with Shared Decision Model100% right coverage1 source
Vinay Prasad, FDACDC Updates COVID-19 Vaccine Guidance for Children, Pregnant Women with Shared Decision Model100% right coverage1 source
Vinay PrasadCOVID Booster Policies Narrow Over-65s, Risk Groups in US, Finland Amid Variant Surge100% right coverage1 source
Vinay PrasadCOVID Booster Policies Narrow Over-65s, Risk Groups in US, Finland Amid Variant Surge100% right coverage1 source
Vinay Prasad, FDAFDA Panel Recommends Monovalent JN.1 COVID Vaccine for Fall, Limits Use to High-Risk Groups100% left coverage1 source
Vinay Prasad, FDAFDA Panel Recommends Monovalent JN.1 COVID Vaccine for Fall, Limits Use to High-Risk Groups100% left coverage1 source
Vinay Prasad, FDAFDA Limits COVID-19 Vaccine Approvals to Older, High-Risk Groups50% left coverage3 sources
Vinay Prasad, FDAFDA Limits COVID-19 Vaccine Approvals to Older, High-Risk Groups50% left coverage3 sources
Vinay Prasad, CoronavirusFDA Limits COVID-19 Shot Approval to Elderly, High-Risk Groups75% left coverage4 sources
Vinay Prasad, CoronavirusFDA Limits COVID-19 Shot Approval to Elderly, High-Risk Groups75% left coverage4 sources